Shorter antibiotics for kidney transplant kidney infections
Part of Infections, Kidney & urinary clinical trials.
This study compares giving antibiotics for 7 days versus 14 days to treat acute kidney infections (pyelonephritis) in people with kidney transplants. It aims to see if the shorter course works just as well and is safer or easier to complete.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 and have a kidney transplant
- You have a kidney infection with fever (at least 38°C) plus urine signs of infection, and your urine culture grows bacteria that match the antibiotic plan
- There is no other confirmed or suspected fever-causing infection besides the urine infection
- Your early response to the first antibiotic is improving within 48–60 hours (fever goes below 38°C and urine symptoms improve)
- Imaging (scan) before treatment shows no blockage and no abscess
- You can sign consent and follow the study rules
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving an antibiotic after a kidney transplant can prevent bloodstream infections. Participants who have bacteria in their urine in the first month after transplant may be eligible.
This trial tests whether giving antibiotics through a vein for 3 days works as well as giving 3 days through a vein followed by 7 days by mouth for a first urinary tract infection (kidney infection). It may help your child recover safely while possibly reducing longer IV treatment.
This study looks at giving anti-infection medications (antibiotics) in a more personalized way soon after a kidney transplant. By carefully adjusting the dose, doctors hope to prevent infections while keeping the new kidney safe.
This study looks at whether continuing an antibiotic called TMP-SMX (Bactrim) for longer helps prevent urinary tract infections after a kidney transplant. If you've already taken it safely for 6 months, you may qualify to continue it for another 6 months or stop, to see which is better.
This trial tests whether people with a specific type of bloodstream infection caused by gram-negative bacteria can safely take antibiotics for only 5 days instead of longer. It may help by reducing antibiotic exposure if your infection source is controlled quickly.
This trial tests a phage (virus that kills bacteria) treatment for women who have had a kidney transplant and keep getting urinary tract infections (UTIs) caused by E. coli bacteria. It aims to see if this therapy can help prevent future infections.
Hear when a new Pyelonephritis Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.